Andrew Gross, MD

Rheumatology clinic chief

Dr. Andrew Gross is an expert in the treatment of lupus and director of clinical programs in Rheumatology. He also is rheumatology clinic chief at UCSF Medical Center. Rheumatology at UCSF — which treats conditions such as rheumatoid arthritis, systemic lupus erythematosus (SLE), spondyloarthritis, scleroderma and vasculitides — is among the top 10 in the nation, according to a ranking by U.S. News & World Report.

In addition to treating patients, Gross conducts research on the deregulation of immune function in patients with systemic lupus erythematosus. Gross earned a medical degree at Tufts University in Boston. He then trained in internal medicine and rheumatology at Tufts-New England Medical Center, and remained there for another year as a faculty member in Rheumatology. He joined the UCSF faculty in 2003 and completed a post-doctoral fellowship at UCSF in Microbiology and Immunology.

Clinics

ILD Program
400 Parnassus Ave., Fifth Floor
San Francisco, CA 94143
Phone: (415) 353-2577
Fax: (415) 353-8944

Lupus Clinic
400 Parnassus Ave., Floor B1
San Francisco, CA 94143
Phone: (415) 353-2497
Fax: (415) 353-2530

Hours: Monday to Friday,
8 a.m. to 4 p.m.

Rheumatoid Arthritis Clinic
400 Parnassus Ave., Floor B-1
San Francisco, CA 94143
Phone: (415) 353-2497
Fax: (415) 353-2530

Hours: Monday to Friday,
8 a.m. – 4 p.m.

Rheumatology Clinic
400 Parnassus Ave., Floor B1
San Francisco, CA 94143
Phone: (415) 353-2497
Fax: (415) 353-2530

Hours: Monday to Friday,
8 a.m. to 4 p.m.

Scleroderma Clinic
400 Parnassus Ave., Floor B1
San Francisco, CA 94143
Phone: (415) 353-4407
Fax: (415) 353-8463

Hours: Monday to Friday; 8 a.m. to 4 p.m.

Conditions & Treatments

Board Certification

Rheumatology, American Board of Internal Medicine

Academic Title

Professor

More about Andrew Gross

Education

Tufts University School of Medicine 1996

Residencies

New England Medical Center, Internal Medicine 1999

Fellowships

New England Medical Center, Rheumatology 2002

Selected Research and Publications

  1. Kushner T, Shinkai K, Fox L, Ying D, Gross A, Balitzer D, Gill R, Brandman D. New presentation of autoimmune hepatitis with erythema multiforme. Hepatology. 2018 Apr; 67(4):1628-1630.
  2. Saeed L, Schmidt TH, Gensler LS, Gross AJ, Fox LP, Scharschmidt TC, Gaensler K, Naik H, Rosenblum MA, Shinkai K. Successful treatment of mucous membrane pemphigoid with bortezomib. JAAD Case Rep. 2018 Jan; 4(1):81-83.
  3. Jiang B, Patino MM, Gross AJ, Leong SPL, Moretto JC, Kashani-Sabet M, Kim KB. Diffuse granulomatous panniculitis associated with anti PD-1 antibody therapy. JAAD Case Rep. 2018 Jan; 4(1):13-16.
  4. Morisset J, Vittinghoff E, Lee BY, Tonelli R, Hu X, Elicker BM, Ryu JH, Jones KD, Cerri S, Manfredi A, Sebastiani M, Gross AJ, Ley B, Wolters PJ, King TE, Kim DS, Collard HR, Lee JS. The performance of the GAP model in patients with rheumatoid arthritis associated interstitial lung disease. Respir Med. 2017 Jun; 127:51-56.
  5. Gonzales JA, Haemel A, Gross AJ, Acharya NR. Management of Uveitis and Scleritis in Necrobiotic Xanthogranuloma. J Ocul Pharmacol Ther. 2017 05; 33(4):325-333.
  6. Wahl E, Gross A, Chernitskiy V, Trupin L, Gensler L, Chaganti K, Michaud K, Katz P, Yazdany J. Validity and Responsiveness of a 10-Item Patient-Reported Measure of Physical Function in a Rheumatoid Arthritis Clinic Population. Arthritis Care Res (Hoboken). 2017 Mar; 69(3):338-346.
  7. Chou A, Schulman JM, Gross AJ, Jordan RC, Ramos DM. Gingival pustules and sterile diffuse sclerosing osteomyelitis as a feature of synovitis, acne, pustulosis, hyperostosis, osteitis (SAPHO) syndrome. Oral Surg Oral Med Oral Pathol Oral Radiol. 2016 May; 121(5):e116-22.
  8. Hua Z, Gross AJ, Lamagna C, Ramos-Hernández N, Scapini P, Ji M, Shao H, Lowell CA, Hou B, DeFranco AL. Requirement for MyD88 signaling in B cells and dendritic cells for germinal center anti-nuclear antibody production in Lyn-deficient mice. J Immunol. 2014 Feb 01; 192(3):875-85.
  9. Wang W, Wang ZJ, Webb EM, Westphalen AC, Gross AJ, Yeh BM. Omental infarction preceded by anatomically upturned omentum. Clin Imaging. 2013 Nov-Dec; 37(6):1125-7.
  10. Bucknor MD, Gross AJ, Link TM. Voriconazole-induced periostitis in two post-transplant patients. J Radiol Case Rep. 2013 Aug; 7(8):10-7.
  11. Shahaf G, Gross AJ, Sternberg-Simon M, Kaplan D, DeFranco AL, Mehr R. Lyn deficiency affects B-cell maturation as well as survival. Eur J Immunol. 2012 Feb; 42(2):511-21.
  12. Prasad AP, George V, Porzig A, Horvai AE, Gross A, Shoback D, Link TM. Progressive craniofacial bone loss after cosmetic surgery at the forehead. Skeletal Radiol. 2012 Apr; 41(4):477-81.
  13. Gross AJ, Proekt I, DeFranco AL. Elevated BCR signaling and decreased survival of Lyn-deficient transitional and follicular B cells. Eur J Immunol. 2011 Dec; 41(12):3645-55.
  14. Gross AJ, Lyandres JR, Panigrahi AK, Prak ET, DeFranco AL. Developmental acquisition of the Lyn-CD22-SHP-1 inhibitory pathway promotes B cell tolerance. J Immunol. 2009 May 01; 182(9):5382-92.
  15. Gillis JZ, Dall'era M, Gross A, Yazdany J, Davis J. Six refractory lupus patients treated with rituximab: a case series. Arthritis Rheum. 2007 Apr 15; 57(3):538-42.
  16. Gross AJ, Hochberg D, Rand WM, Thorley-Lawson DA. EBV and systemic lupus erythematosus: a new perspective. J Immunol. 2005 Jun 01; 174(11):6599-607.

Publications are derived from MEDLINE/PubMed and provided by UCSF Profiles, a service of the Clinical & Translational Science Institute (CTSI) at UCSF. Researchers can make corrections and additions to their publications by logging on to UCSF Profiles.